Press Releases

September 4, 2013 • 9:24 AM EDT

Amarantus Bioscience Holdings Announces Private Placement of Convertible Debentures and Warrants

September 3, 2013 • 9:00 AM EDT

Amarantus Appoints Dr. Colin Bier to Advisory Board for LymPro Commercialization

August 29, 2013 • 10:11 AM EDT

Amarantus CEO to Present at the 2nd Annual European Investing and Partnering Summit in Helsinki

August 27, 2013 • 11:14 AM EDT

Amarantus Announces Two New Independent Peer-Reviewed Publications for MANF

August 19, 2013 • 4:05 PM EDT

Amarantus Strengthens Balance Sheet With Preferred Stock Transaction

August 12, 2013 • 9:21 AM EDT

Amarantus Announces Positive Orphan Data for MANF in Retinitis Pigmentosa

August 6, 2013 • 9:06 AM EDT

Amarantus Issues Mid-Year President's Letter to Shareholders

June 26, 2013 • 7:30 AM EDT

Amarantus to Present at OneMedForum New York on June 27

June 21, 2013 • 7:30 AM EDT

Amarantus to Evaluate LymPro Test as a Diagnostic and Prognostic for Chronic Traumatic Encephalopathy

June 19, 2013 • 7:30 AM EDT

Amarantus Reports Positive Results on MANF Neuroprotective Properties Demonstrated in Preclinical Study in China